Retatrutide 20mg Pen
Order the Retatrutide 20mg prefilled pen — 200 clicks at 0.1mg, no reconstitution. Janoshik batch RET-20-C-2604-001 ships at 99.841% HPLC, the highest published purity in our catalogue. Same-day Dubai dispatch before 4 PM, next-day across the UAE.
CAS 2381089-83-2
RET-20-C-2604-001
200 clicks × 0.1mg
Next-day other emirates
Janoshik Analytical report for pen batch RET-20-C-2604-001 shows 99.841% HPLC purity at 22.51 mg/mL measured concentration — Task #150762, analyzed 23 Apr 2026. Filed alongside the vial-lot batch-release reports in the COA library. New to reading these reports? See the Peptide COA & HPLC Purity Guide, or follow the Janoshik COA verification walkthrough.
Open Purity Report →Janoshik Tested.
Verified Purity.
The current Retatrutide 20mg Pen lot is published with Janoshik Analytical at 99.841% HPLC purity and 22.51 mg/mL measured concentration — Janoshik Task #150762, analyzed 23 Apr 2026 (verification key APSLYZGYW4KA). Review the purity report below, or open the full report.
Janoshik purity report preview — open full report
Retatrutide FAQ
What is Retatrutide?
Retatrutide (LY-3437943) is a novel synthetic triple-agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. It is the first compound to target all three metabolic pathways in a single molecule. In the 48-week Phase 2 trial (n=338), the highest-dose cohort achieved 24.2% mean body weight reduction. CAS: 2381089-83-2.
How does triple agonism differ from semaglutide?
Semaglutide is a single-agonist (GLP-1 only). Tirzepatide is a dual-agonist (GLP-1 + GIP). Retatrutide is the first triple-agonist — activating GLP-1 for satiety signalling, GIP for insulin secretion, and glucagon for hepatic energy expenditure and thermogenesis. This three-pathway approach addresses both energy intake and expenditure simultaneously.
What is the purity?
The current Retatrutide 20mg Pen batch RET-20-C-2604-001 is published with Janoshik Analytical at 99.841% HPLC purity and 22.51 mg/mL measured concentration (Task #150762, analyzed 23 Apr 2026, verification key APSLYZGYW4KA). See the full report in the COA library entry.
What are the pricing tiers?
AED 1,200 per pen (single), AED 3,300 for a 3-pack (AED 1,100/pen), and AED 5,000 for a 5-pack (AED 1,000/pen). Free 2-4 hour UAE delivery on all orders.
How should the pen be stored?
Store at +2 to +8°C (refrigerated). Do not freeze. The Pen is pre-filled — no reconstitution needed. Each pen contains 20mg of Retatrutide delivered across 200 precision clicks at 0.1mg per click. Cold-chain delivered to maintain integrity.
What Phase 2 data exists?
The pivotal Phase 2 trial was published in the New England Journal of Medicine (2023). 338 adults with obesity were randomised across multiple dose cohorts over 48 weeks. The highest-dose group achieved 24.2% mean body weight reduction. 100% of participants in that cohort achieved ≥5% weight loss by week 24. Secondary endpoints showed significant reductions in liver fat content and improvements in cardiometabolic markers.
Is Retatrutide available in the UAE?
Retatrutide is available in Dubai and across the UAE under UAE MoHAP Circular 17/2022 governing research-use compounds. It is not approved for human consumption, therapeutic use, or veterinary use. See our UAE research peptide compliance guide for full detail, or the Retatrutide page for all formats and pricing.
Order Retatrutide — Dubai & UAE
20mg Pen • 200 clicks × 0.1mg • From AED 1,000/pen • Same-day Dubai delivery • WhatsApp confirmation in minutes.
More Retatrutide research formats
Same triple-agonist research compound across pen and vial formats. The 30mg flagship is Janoshik-COA-verified at 99.262% HPLC.
Retatrutide 10mg Vial
10mg lyophilized vial · triple-agonist LY-3437943 · cold-chain
Retatrutide 30mg Pen
30mg FlexiPen · 300 clicks @ 0.1mg · Janoshik COA 99.262%
Browse research stacks → — paired Retatrutide + BPC-157 and fat-loss stacks available at 5% off.